-
Diabetes Drug Patients Use For Weight Loss May Have Heart Benefits
Known by their brand names like Ozempic and Wegovy, these approved treatments for type 2 diabetes patients have made headlines recently for their effectiveness at treating obesity and helping people with or without diabetes lose weight.
-
Novo Nordisk to Slash U.S. Insulin Prices by Up to 75%, Following Move by Eli Lilly
Novo Nordisk is planning to slash the price of several insulin drugs by up to 75% in the U.S., following a similar move by Eli Lilly.
-
What Is Insulin?
Insulin plays an essential role in the human body, especially for the 37.3 million people in the U.S. who have diabetes, according to the National Diabetes Statistics Report.
-
FDA Approves First Drug to Delay Progression of Type 1 Diabetes
The FDA approved the new diabetes treatment Tzield, an injectable treatment that can slow the progression of Type 1 diabetes in patients with stage 2 and delay the need for injectable insulin by two years.
-
Episode 1: Meet Chanteé
Episode 1: Meet Chanteé. After dedicating her life to helping others as a home healthcare worker, a Type 2 Diabetes diagnosis upended Chanteé Elliott-Davis’ life during the pandemic.
Promoted By Dexcom -
Take Control of Your Health
Being diagnosed with a serious illness can be overwhelming and isolating, but witnessing others navigate those challenges and lead fulfilling lives can motivate and inspire patients while signaling that they are not alone in their health journeys. That’s where Fixing Us comes in.
Promoted By Dexcom -
Why Is Insulin Still So Expensive for Diabetes Patients in the U.S.?
More than 1 in ten patients who use insulin report spending a significant portion of their income on the drug.